CorMedix Inc. CRMD
5.67 USD +0.11 (+2.01%)
Nov 4, 2026, 12:52 PM EST
5.58 Day range 5.79
5.30 52-week range 13.02
- YTD
- -51.23%
- 1 year
- -50.33%
Analyst view
Price target (mean) 16.25 +186.5% upside
Now 5.67
- Target (low)
- 11.00
- Target (mean)
- 16.25
- Target (high)
- 19.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy3
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.05 | 0.03 – 0.06 | -0.26 | +119.2% | 19.97M | 0.0% | 4 |
| Next quarter | 0.15 | 0.15 – 0.15 | -0.25 | +160.0% | 31.02M | 0.0% | 1 |
| Current year | -0.4975 | -0.54 – -0.45 | -0.91 | +45.3% | 32.25M | 0.0% | 4 |
| Next year | 0.5775 | 0.24 – 0.94 | -0.4975 | +216.1% | 113.29M | +251.3% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 31, 2024 | Needham | Maintained | Buy | Buy |
| Aug 15, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 15, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 25, 2024 | Truist Securities | Maintained | Buy | Buy |
| Jun 19, 2024 | Needham | Reiterated | Buy | Buy |
| May 13, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 9, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 9, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 13, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 12, 2024 | Needham | Maintained | Buy | Buy |
| Jan 31, 2024 | Truist Securities | Maintained | Buy | Buy |
| Nov 15, 2023 | Needham | Maintained | Buy | Buy |
| Nov 15, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 15, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Nov 15, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Aug 10, 2023 | RBC Capital | Initiated | — | Outperform |
| Aug 8, 2023 | Needham | Maintained | Buy | Buy |
| Jun 21, 2023 | Needham | Reiterated | Buy | Buy |
| May 19, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| May 16, 2023 | Needham | Reiterated | Buy | Buy |
| Mar 31, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Mar 31, 2023 | Needham | Reiterated | — | Buy |
| Mar 3, 2023 | Needham | Reiterated | — | Buy |
| Mar 1, 2023 | JMP Securities | Maintained | — | Market Perform |
| Nov 11, 2022 | Needham | Maintained | — | Buy |
| Aug 12, 2022 | Truist Securities | Maintained | — | Buy |
| Aug 9, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Aug 9, 2022 | Needham | Maintained | — | Buy |
| May 14, 2021 | Needham | Maintained | — | Buy |